Ibrance boosts effect of HIF2A inhibition in renal cancer

DISEASE CATEGORY: Cancer

INDICATION: Renal cancer

A team led by William Kaelin Jr., a winner of this year's Nobel Prize

Read the full 186 word article

User Sign In